145 related articles for article (PubMed ID: 24511042)
1. Metabolic treatment of cancer: intermediate results of a prospective case series.
Schwartz L; Buhler L; Icard P; Lincet H; Steyaert JM
Anticancer Res; 2014 Feb; 34(2):973-80. PubMed ID: 24511042
[TBL] [Abstract][Full Text] [Related]
2. A combination of alpha lipoic acid and calcium hydroxycitrate is efficient against mouse cancer models: preliminary results.
Schwartz L; Abolhassani M; Guais A; Sanders E; Steyaert JM; Campion F; Israël M
Oncol Rep; 2010 May; 23(5):1407-16. PubMed ID: 20372858
[TBL] [Abstract][Full Text] [Related]
3. The Long-Term Survival of a Patient With Stage IV Renal Cell Carcinoma Following an Integrative Treatment Approach Including the Intravenous α-Lipoic Acid/Low-Dose Naltrexone Protocol.
Berkson BM; Calvo Riera F
Integr Cancer Ther; 2018 Sep; 17(3):986-993. PubMed ID: 29258346
[TBL] [Abstract][Full Text] [Related]
4. Adding a combination of hydroxycitrate and lipoic acid (METABLOC™) to chemotherapy improves effectiveness against tumor development: experimental results and case report.
Guais A; Baronzio G; Sanders E; Campion F; Mainini C; Fiorentini G; Montagnani F; Behzadi M; Schwartz L; Abolhassani M
Invest New Drugs; 2012 Feb; 30(1):200-11. PubMed ID: 20931262
[TBL] [Abstract][Full Text] [Related]
5. Revisiting the ALA/N (alpha-lipoic acid/low-dose naltrexone) protocol for people with metastatic and nonmetastatic pancreatic cancer: a report of 3 new cases.
Berkson BM; Rubin DM; Berkson AJ
Integr Cancer Ther; 2009 Dec; 8(4):416-22. PubMed ID: 20042414
[TBL] [Abstract][Full Text] [Related]
6. The long-term survival of a patient with pancreatic cancer with metastases to the liver after treatment with the intravenous alpha-lipoic acid/low-dose naltrexone protocol.
Berkson BM; Rubin DM; Berkson AJ
Integr Cancer Ther; 2006 Mar; 5(1):83-9. PubMed ID: 16484716
[TBL] [Abstract][Full Text] [Related]
7. Alpha-lipoic acid treatment of 31 patients with sore, burning mouth.
Steele JC; Bruce AJ; Drage LA; Rogers RS
Oral Dis; 2008 Sep; 14(6):529-32. PubMed ID: 18266840
[TBL] [Abstract][Full Text] [Related]
8. Phase II study of subcutaneously administered interleukin-2 in combination with medroxyprogesterone acetate and antioxidant agents as maintenance treatment in advanced cancer responders to previous chemotherapy.
Mantovani G; Macciò A; Madeddu C; Mulas C; Massa E; Astara G; Ferreli L; Mudu MC; Gramignano G; Murgia V; Lusso MR; Mocci M; Cardia A; Mura L
Oncol Rep; 2002; 9(4):887-96. PubMed ID: 12066227
[TBL] [Abstract][Full Text] [Related]
9. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
Lee YC; McCrystal MR; Christmas TI
N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
[TBL] [Abstract][Full Text] [Related]
10. Out of Warburg effect: An effective cancer treatment targeting the tumor specific metabolism and dysregulated pH.
Schwartz L; Seyfried T; Alfarouk KO; Da Veiga Moreira J; Fais S
Semin Cancer Biol; 2017 Apr; 43():134-138. PubMed ID: 28122260
[TBL] [Abstract][Full Text] [Related]
11. Oral treatment with alpha-lipoic acid improves symptomatic diabetic polyneuropathy: the SYDNEY 2 trial.
Ziegler D; Ametov A; Barinov A; Dyck PJ; Gurieva I; Low PA; Munzel U; Yakhno N; Raz I; Novosadova M; Maus J; Samigullin R
Diabetes Care; 2006 Nov; 29(11):2365-70. PubMed ID: 17065669
[TBL] [Abstract][Full Text] [Related]
12. Randomized comparison of total androgen blockade alone versus combined with weekly epirubicin in advanced prostate cancer.
Pummer K; Lehnert M; Stettner H; Hubmer G
Eur Urol; 1997; 32 Suppl 3():81-5. PubMed ID: 9267791
[TBL] [Abstract][Full Text] [Related]
13. Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group.
Emons G; Ortmann O; Teichert HM; Fassl H; Löhrs U; Kullander S; Kauppila A; Ayalon D; Schally A; Oberheuser F
Cancer; 1996 Oct; 78(7):1452-60. PubMed ID: 8839551
[TBL] [Abstract][Full Text] [Related]
14. Diethylstilboestrol versus bicalutamide in hormone refractory prostate carcinoma: a prospective randomized trial.
Manikandan R; Srirangam SJ; Pearson E; Brown SC; O'Reilly P; Collins GN
Urol Int; 2005; 75(3):217-21. PubMed ID: 16215308
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant fractionated high-dose-rate intracavitary brachytherapy after external beam radiotherapy in Tl and T2 nasopharyngeal carcinoma.
Lu JJ; Shakespeare TP; Tan LK; Goh BC; Cooper JS
Head Neck; 2004 May; 26(5):389-95. PubMed ID: 15122654
[TBL] [Abstract][Full Text] [Related]
16. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
17. Extended-field radiotherapy and high-dose-rate brachytherapy in carcinoma of the uterine cervix: clinical experience with and without concomitant chemotherapy.
Sood BM; Gorla GR; Garg M; Anderson PS; Fields AL; Runowicz CD; Goldberg GL; Vikram B
Cancer; 2003 Apr; 97(7):1781-8. PubMed ID: 12655536
[TBL] [Abstract][Full Text] [Related]
18. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
Piver MS
Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
[TBL] [Abstract][Full Text] [Related]
19. A phase II study of cisplatin and 5-fluorouracil with concurrent hyperfractionated thoracic radiation for locally advanced non-small-cell lung cancer: a preliminary report from the Okayama Lung Cancer Study Group.
Segawa Y; Ueoka H; Kiura K; Kamei H; Tabata M; Sakae K; Hiraki Y; Kawahara S; Eguchi K; Hiraki S; Harada M
Br J Cancer; 2000 Jan; 82(1):104-11. PubMed ID: 10638975
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant chemotherapy followed by concurrent chemo-radiation therapy in locally advanced nasopharyngeal carcinoma.
Al-Amro A; Al-Rajhi N; Khafaga Y; Memon M; Al-Hebshi A; El-Enbabi A; El-Husseiny G; Radawi A; Belal A; Allam A; El-Sebaie M
Int J Radiat Oncol Biol Phys; 2005 Jun; 62(2):508-13. PubMed ID: 15890594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
